dreamstime_l_32081573_edited.jpg

Helping Pharma

Win in Digital

 

A science-first consultancy bridging the gap between innovation and business impact

KHH.jpeg

"It's not easy to build a case for digital health and quantify the business impact. Blackletter was able to articulate the clear value to the business and 'sell' the work internally. With a VC and executive mindset, definitely not your traditional innovation consultants"
 
Kristian Hart-Hansen, CEO
LEO Pharma's Innovation Lab ('15-'20)

"It's difficult to keep track of the rapidly changing digital environment but Blackletter's sophisticated business-focused, fast-paced and customized approach made immediate business impact"
 
Kamil Hamied, Head of Global Strategy, EU CEO
Cipla ('12 - '15)

Kamil.jpeg
Avi.jpeg

"As a niche life sciences investment bank, it's hard to stay up to date on the latest teams and technologies, but Blackletter's deep scientific networks have been extremely helpful in generating proprietary dealflow. I would place Blackletter in the top 5% of innovation consultants"
 
Avi Grewal, CEO
Cinaport Capital

1.jpeg

"Together with Blackletter, we identified 40 'stealth' companies in one of the world's most innovative ecosystems and designed pilots to onboard. I was impressed with Blackletter's ability to produce innovation quickly and their process of operationalizing it.
 
Hanne Kusk Jacobsen, Director Clinical Operations
Lundbeck

jacob.jpeg

"A refreshing approach to external innovation that translates theory into practical business results. Blackletter's models and access to leading innovation teams and ecosystems are the future of how corporations can build edge over their competitors in non-obvious ways."
 
Jacob Fish, Professor
Columbia University

"Blackletter is an exceptional agency. We needed to understand where the market is going to be, not where it is right now and they impressed me with a broad analysis of Israeli technology companies and more importantly with their ability to quickly synthesize the opportunities to what matters for the business.’’
 

Sebastien G. St-Louis,
Co-founder & CEO, HEXO Corp.

1614615739803.jpeg

“There are so many challenges in doing digital in Pharma because it's not our core business. We develop drugs, not build software”

- VP, Digital Health, Top 5 Pharma

 

Our Services

diagnostics

Ensure your digital initiatives are aligned with the highest unmet needs of the business and future growth aspirations

strategy

Unlock the power of digital to change the trajectory of your business and achieve extraordinary results

landscape

Keep a pulse on the rapidly-evolving digital ecosystem and gain a macro view of the industry to inform strategic choices

business cases

Justify continued investment in digital by crafting a data-driven financial case for ongoing capital allocation

partnerships

Find the right digital partners ahead of the competition and design agile pilots to quickly validate core hypotheses

diligence

Conduct detailed science-first commercial diligence on partnership and investment opportunities

launch

Design a compelling Go-to-Market strategy to overachieve your revenue targets

integration

Onboard new digital technology investments into the business, preserving the best of each entity's culture while unlocking new growth potential